Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Foot Dystonia Treatment by Botulinum Toxin Injections in Parkinson Disease
NCT00909883Phase 3Unknown
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Sep 2009
- Primary completion
- Sep 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of neuronox in focal foot dystonia, sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Status: unknown.
02
Drugs
neuronox
03
Conditions
focal foot dystonia
Beyond the preview
Go deeper on NCT00909883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00909883.